Your browser doesn't support javascript.
loading
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130.
Badve, Sunil S; Penault-Llorca, Frédérique; Reis-Filho, Jorge S; Deurloo, Regula; Siziopikou, Kalliopi P; D'Arrigo, Corrado; Viale, Giuseppe.
Afiliación
  • Badve SS; Department of Pathology and Lab Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Penault-Llorca F; Imagerie Moléculaire et Stratégies Théranostiques, Centre de Lutte Contre le Cancer Jean Perrin, Université Clermont Auvergne, Clermont Ferrand, France.
  • Reis-Filho JS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Deurloo R; Oncology Biomarker Development, F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Siziopikou KP; Breast Pathology Section, Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • D'Arrigo C; Histopathology, Poundbury Cancer Institute, Dorchester, UK.
  • Viale G; University of Milan, Milan, Italy.
J Natl Cancer Inst ; 114(5): 664-675, 2022 05 09.
Article en En | MEDLINE | ID: mdl-34286340

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Natl Cancer Inst Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Natl Cancer Inst Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos